Filtered by category "Marijuana Insights"

Getting Busy With Bioplastics: New Applications for an Old Idea

By William Sumner, Hemp Business Journal Contributor Since the 2018 Farm Bill was signed into law just before the new year and the installation of the 116th U.S. Congress, the hemp industry has been bristling with activity. For the most part, business has been centered around potential medical applications for hemp’s most famous component, cannabidiol […]
Read more

Ask Our Experts 1/13/2019

  Ask Our Experts: The Impact of Excess Cannabis Inventory in Oregon and Other Regulated Markets By Beau Whitney, Senior Economist, New Frontier Data   Q: I am seeing a lot of news about excess inventory in Oregon and other regulated cannabis markets. What is the impact of this excess inventory, and what can be done […]
Read more

Considerations for Cannabis Stakeholders in Light of Harborside Health Center Decision

Considerations for Cannabis Stakeholders in Light of Harborside Health Center Decision By Selvan Boominathan, Manager, National Tax Services, for CohnReznick Late last year, the Tax Court published its opinion in Patients Mutual Assistance Collective Corp. (d.b.a. Harborside Health Center) v. Commissioner, 151 T.C. 11 (2018). Harborside is a medical cannabis dispensary operating legally under [...]
Read more

2018 Cannabis Mergers and Acquisitions Highlights

The North American cannabis sector established market legitimacy in 2018 with word of outside interests like Constellation Brands (maker of beer, wine, and spirits) investing heavily in the space. Likewise, a USD $1.8 billion buy-in by Altria group (owner of Marlboro) for a 45% stake in cannabinoid company, Cronos Group, marked bullish involvement by a Big Tobacco […]
Read more

Market Dynamics Worth Tracking Throughout 2019

Market Dynamics Worth Tracking Throughout 2019 By J.J. McCoy, Senior Managing Editor, New Frontier Data With each new year comes a fresh reminder that the only constant is change, an axiom with particular relevance in the nascent and mercurial legal cannabis industry. As the calendar turns, these are among the hottest topics to track throughout […]
Read more

Recap: Making Profitable Hay from Passage of the Farm Bill

By William Sumner, Hemp Business Journal Contributor Late last month, Congress passed one of the most significant bills in recent memory: the 2018 Farm Bill. In addition to mandating a number of boilerplate provisions(such as expanded farm subsidies), the new law legalizes hemp for the first time in half a century; yet, the devil is […]
Read more

2019 U.S. Cannabis Outlook

Continued dramatic growth is expected for the legal cannabis industry in 2019. As of January 1, now 33 states plus the District of Columbia (D.C.) have legalized cannabis for medicinal use, with 10 states and D.C. permitting adult use. Medical-use sales are slated to begin in four states (Arkansas, Louisiana, North Dakota, and Ohio). Per […]
Read more

2018 Cannabis Highlights

2018 Cannabis Highlights by Numbers Nearly $2 billion With CBD sales in the U.S. are expected to reach $534 million in 2018, growing to nearly $2 billion by 2022. More Than 30 Countries The global cannabis market is expanding rapidly, with Canada having joined Uruguay as the first countries to legalize adult-use markets; more than […]
Read more

Ask Our Experts 1/06/2019

Ask Our Experts: The Federal Reserve and Fears of Recession By Beau Whitney, Senior Economist, New Frontier Data   Q: The Federal Reserve just increased interest rates to slow the growth of the U.S. economy, but the stock market has recently seen a steep decline, based in part to fears of a global recession. What […]
Read more

Back to Basics: Laurel Alterman and William A. Gibson v. Commissioner of Internal Revenue

By Greg Pelucacci, CohnReznick senior associate In the rapidly growing industry of cannabis, there are several important concepts for owners to understand. One of the most popular topics would be Internal Revenue Code (IRC) Section (§) 280E: Passed in 1982, that code section prohibits companies that traffic Controlled Substances Act (CSA) Schedule I or II […]
Read more
Top